Chitti Bhargava, Stefanov Dimitre G, Potters Louis, Andrews Janna
Department of Radiation Medicine, Northwell Health Cancer Institute, Lake Success, New York.
Donald and Barabar Zucker School of Medicine at Hofstra/Northwell Health, Zucker School of Medicine, Hempstead, New York.
Adv Radiat Oncol. 2024 Jan 4;9(4):101436. doi: 10.1016/j.adro.2023.101436. eCollection 2024 Apr.
Disparities have been reported in women treated for breast cancer (BrCa). This study examines potential disparities in BrCa treatment offered based on race and age from a multicenter radiation department.
We identified 901 patients with early stage BrCa who received curative intent radiation therapy (RT) between 2004 and 2018. Data extracted included age, race, disease stage, treatment technique, treatment dates, and fractionation. Patient race was recorded as Asian, Black, Hispanic, and White. RT technique delivered was classified as a type of external beam radiation therapy or brachytherapy/intraoperative radiation therapy. Fractionation schema were defined as 1) standard fractionation, 1.8-2 Gy; 2) hypofractionation, 2.5-2.67 Gy; 3) accelerated partial breast irradiation (APBI), 3.4 Gy - 4.25 Gy, and 4) intraoperative radiation therapy, single dose of 20 Gy. Stage was recorded using TNM staging. The χ test and a multivariable multinomial logistic regression model were used to assess whether patient characteristics, such as age, race, or stage influenced fractionation schemes. Results with 2-sided values < .05 were considered statistically significant.
Racial composition of the study was 13.8% Asian, 22% Black, 29%, White, and 35.1% Hispanic. Mean age was 61 and was divided into 4 age range groups: 30 to 49 (n = 160), 50 to 59 (n = 231), 60 to 69 (n = 294), and ≥70 years (n = 216). In addition, 501 patients (56%) received hypofractionation, 342 (38.8%) received standard fractionation, and 58 (7.1%) received APBI, respectively. For all groups, hypofractionation became more common over time. Age ≥70 years was associated with 9 times higher odds of APBI and 14 times higher odds of hypofractionation, compared with age 30 to 49 years. After adjusting for the other predictors in a multivariable multinomial logistic regression model, the race distribution differed among the 3 groups ( = .03), with a smaller percentage of Hispanics and higher percentage of blacks in the standard group.
This study of a diverse cohort of patients with breast cancer failed to identify treatment differences associated by race. The study found an association between age and hypofractionation.
已有报道称乳腺癌(BrCa)患者的治疗存在差异。本研究从一个多中心放疗科调查了基于种族和年龄的BrCa治疗潜在差异。
我们确定了901例2004年至2018年间接受根治性放疗(RT)的早期BrCa患者。提取的数据包括年龄、种族、疾病分期、治疗技术、治疗日期和分割方式。患者种族记录为亚洲人、黑人、西班牙裔和白人。所采用的RT技术分为外照射放疗或近距离放疗/术中放疗。分割方案定义为:1)标准分割,1.8 - 2 Gy;2)大分割,2.5 - 2.67 Gy;3)加速部分乳腺照射(APBI),3.4 Gy - 4.25 Gy,以及4)术中放疗,单次剂量20 Gy。分期采用TNM分期记录。采用χ检验和多变量多项逻辑回归模型评估年龄、种族或分期等患者特征是否影响分割方案。双侧P值<0.05的结果被认为具有统计学意义。
研究的种族构成是13.8%为亚洲人,22%为黑人,29%为白人,35.1%为西班牙裔。平均年龄为61岁,分为4个年龄范围组:30至49岁(n = 160),50至59岁(n = 231),60至69岁(n = 294),以及≥70岁(n = 216)。此外,分别有501例患者(56%)接受大分割,342例(38.8%)接受标准分割,58例(7.1%)接受APBI。对于所有组,随着时间推移大分割变得更为常见。与30至49岁相比,≥70岁的患者接受APBI的几率高9倍,接受大分割的几率高14倍。在多变量多项逻辑回归模型中对其他预测因素进行调整后,3组之间的种族分布存在差异(P = 0.03),标准组中西班牙裔的比例较小,黑人的比例较高。
这项对不同乳腺癌患者队列的研究未能发现与种族相关的治疗差异。该研究发现年龄与大分割之间存在关联。